Researchers make progress understanding a rare pediatric cancer

Investigators at the Cumming School of Medicine have made key new findings about an extremely rare childhood cancer called neurocutaneous melanocytosis. This malignant cancer is characterized by an excessive growth of melanin-producing cells in both the skin and the brain. The study’s authors found potential drug targets for the disease by using a molecular analysis of patient tumour cells grown in animal models. The study was led by Drs. Aru Narendran and Ronald Anderson, in the division of hematology, oncology and transplant at the Alberta Children’s Hospital. Read more here.